OCRA News OCRA-Funded Study Reveals Promising Therapeutic Option for Boosting Ovarian Cancer Immune Response
OCRA News New Bioinformatics Tool Shows Promise for Matching Cancer Patients with Optimal Treatment Combinations
Research First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer
Research OCRA-Funded Study Pinpoints Partner Proteins That May Contribute to Ovarian Cancer Tumor Growth